Obstetrics & Gynecology · New Hyde Park, NY
NPI
1568433001
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3111 New Hyde Park Rd
New Hyde Park, NY, 11042
Phone (516) 365-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
2,226 services
Medicare patients, 2024
625
Average age 75
Drug cost, 2024
$105K
713 prescriptions
Company payments, 2025
$196
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendy B Fried-Oginski was code G0328 (colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous), 525 times for 525 patients. In total Wendy B Fried-Oginski billed 2,226 services in 36 codes, and Medicare paid $125K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 525 | 525 | $17.69 | $9,287 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 364 | 364 | $46.89 | $17K |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 241 | 219 | $105.60 | $25K |
| 99214 Office E&M - Established | Office | 236 | 166 | $113.96 | $27K |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 219 | 219 | $52.03 | $11K |
| 99459 Office/Outpatient Services | Office | 179 | 143 | $21.82 | $3,906 |
| 77080 Standard X-ray | Office | 147 | 147 | $46.43 | $6,825 |
| 99213 Office E&M - Established | Office | 115 | 92 | $80.92 | $9,306 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 58 | 58 | $22.30 | $1,293 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 31 | 28 | $93.61 | $2,902 |
| 57150 Other Organ Systems | Office | 25 | 14 | $53.24 | $1,331 |
| 58558 Other Organ Systems | Facility | 15 | 15 | $214.85 | $3,223 |
By year: 2022 $119K for 2,020 services; 2023 $102K for 1,788 services; 2024 $125K for 2,226 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 525 | 525 | $17.69 | $9,287 |
Medicare prescription drug claims, 2024
In 2024, the drug Wendy B Fried-Oginski prescribed most often to Medicare patients was Estradiol, with 230 prescriptions and refills. In total Wendy B Fried-Oginski wrote 713 Medicare prescriptions that cost $105K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 230 | 568 | 102 | $31K |
| Yuvafem Estradiol | 117 | 301 | 42 | $21K |
| Clobetasol Propionate Generic | 42 | 64 | 24 | $1,858 |
| Valacyclovir Valacyclovir Hcl | 37 | 97 | 14 | $2,523 |
| Estring Estradiol | 33 | 98 | 13 | $18K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 25 | 29 | 15 | $312 |
| Imvexxy Estradiol | 22 | 58 | Under 11 | $13K |
| Nystatin Generic | 18 | 19 | 13 | $250 |
| Progesterone Progesterone, Micronized | 18 | 52 | Under 11 | $910 |
| Misoprostol Generic | 16 | 16 | 15 | $52.09 |
| Vagifem Estradiol | 11 | 20 | Under 11 | $3,496 |
| Premarin Estrogens, Conjugated | 11 | 19 | Under 11 | $3,218 |
Brand drugs: 128 claims; generic drugs: 585 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendy B Fried-Oginski $196 ($196 in general payments such as food, travel and fees) from 1 company. The largest payer was Hologic Sales and Service, LLC with $196.
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC HOLX | 3 | $196 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.